Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics
Journal of Extracellular Biology · 2024-11 · 3 (11)
DOI: 10.1002/jex2.70017 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Extracellular Biology, online erschienen am 30.10.2024. Verfasst von Stephanie R Jackson Cullison und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Cutaneous Biology Thomas Jefferson University Philadelphia Pennsylvania USA. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 461 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The translation of pre‐clinical anti‐cancer therapies to regulatory approval has been promising, but slower than hoped. While innovative and effective treatments continue to achieve or seek approval, setbacks are often attributed to a lack of efficacy, failure to achieve clinical endpoints, and dose‐limiting toxicities. Successful efforts have been characterized by the development of therapeutics designed to specifically deliver optimal and effective dosing to tumour cells while minimizing off‐target toxicity. Much effort has been devoted to the rational design and application of synthetic nanoparticles to serve as targeted therapeutic delivery vehicles. Several challenges to the successful application of this modality as delivery vehicles include the induction of a protracted immune response that results in their rapid systemic clearance, manufacturing cost, lack of stability, and their biocompatibility. Extracellular vesicles (EVs) are a heterogeneous class of endogenous biologically produced lipid bilayer nanoparticles that mediate intercellular communication by carrying bioactive macromolecules capable of modifying cellular phenotypes to local and distant cells. By genetic, chemical, or metabolic methods, extracellular vesicles (EVs) can be engineered to display targeting moieties on their surface while transporting specific cargo to modulate pathological processes following uptake by target cell populations. This review will survey the types of EVs, their composition and cargoes, strategies employed to increase their targeting, uptake, and cargo release, and their potential as targeted anti‐cancer therapeutic delivery vehicles.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Cutaneous Biology Thomas Jefferson University Philadelphia Pennsylvania USA.
- Rowan-Virtua School of Osteopathic Medicine Rowan University Stratford New Jersey USA.
- Departments of Pharmacology Physiology, and Cancer Biology, Thomas Jefferson University Philadelphia Pennsylvania USA.
- Department of Otolaryngology - Head and Neck Surgery Thomas Jefferson University Philadelphia Pennsylvania USA.
ORCID-Profile: Mỹ G Mahoney
Förderung
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Jackson Cullison, S. R., Flemming, J. P., Karagoz, K., Wermuth, P. J., & Mahoney, M. G. (2024). Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics. Journal of Extracellular Biology, 3(11). https://doi.org/10.1002/jex2.70017
Vancouver
Jackson Cullison SR, Flemming JP, Karagoz K, Wermuth PJ, Mahoney MG. Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics. Journal of Extracellular Biology. 2024;3(11). doi:10.1002/jex2.70017
BibTeX
@article{JacksonCullison2024,
author = {Jackson Cullison, Stephanie R and Flemming, Joseph P and Karagoz, Kubra and Wermuth, Peter J and Mahoney, Mỹ G},
title = {Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics},
journal = {Journal of Extracellular Biology},
year = {2024},
volume = {3},
number = {11},
doi = {10.1002/jex2.70017}
}
EUVIMED